Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Body Water Content in Cyanotic Congenital Heart Disease Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Body Water Content in Cyanotic Congenital Heart Disease conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Body Water Content in Cyanotic Congenital Heart Disease Clinical research trials and Body Water Content in Cyanotic Congenital Heart Disease health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Body Water Content in Cyanotic Congenital Heart Disease. Body Water Content in Cyanotic Congenital Heart Disease Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Body Water Content in Cyanotic Congenital Heart Disease clinical trial. Test subjects typically receive the most expert healthcare available for their Body Water Content in Cyanotic Congenital Heart Disease condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "B" Clinical Trials Conditions > Body Water Content in Cyanotic Congenital Heart Disease

Body Water Content in Cyanotic Congenital Heart Disease



Body Water Content in Cyanotic Congenital Heart Disease

For Condition: Heart Defects, Congenital
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) ,
Synopsis: Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.
Details:
Eligibility:
Study Type:
  Observational, Natural History, Case Control
Minimum Age/Maximum Age: 17 Years/60 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Resting blood pressure below 140/90
Total Enrollment: 

Location and Contact Information:

University of Vermont
Burlington,  Vermont,  05401
United States
 


Additional Information:
Study ID Numbers:
  NCRR-M01RR00109-0737;  M01RR00109
Study Start Date: 
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000107

Other Heart Defects, Congenital Studies:
1. Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults with Repaired or Palliated Conotruncal Cardiac Defects

2. Body Water Content in Cyanotic Congenital Heart Disease

3. Study of Triostat in Infants during Heart Surgery

4. Liothyronine in Children with Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure

Related Studies:

Other Heart Defects, Congenital Clinical Trials
Other Vermont Clinical Trials
Other Burlington Clinical Trials

Body Water Content in Cyanotic Congenital Heart Disease

Modify your Search

  Other Heart Defects, Congenital Clinical Trials
  Other Vermont Clinical Trials
  Other Burlington Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103